Research presented at the 2026 meeting of the american society of clinical oncology suggests that glp-1s may have a potential role in reducing the risk of progression of certain cancers related to obesity. The findings indicate a possible link between glp-1s and a lower risk of progression for some obesity-related cancers. This potential benefit is being reported in relation to certain cancers associated with obesity.